WHO ICTRP trial

A Randomized, Controlled, Multicenter Clinical Trial of Kangai Injection in…

ChiCTR-TRC-13003885 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR-TRC-13003885
Public title A Randomized, Controlled, Multicenter Clinical Trial of Kangai Injection in Combination with Chemotherapy OFL in Treatment of Gastric Cancer
Scientific title Post-marketing Clinical Research on Kangai Injection in Treatment of Malignant Neoplasm
Primary sponsor Guang’anmen Hospital affiliatied to China Academy of Chinese Medical Sciences
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase Post-market
Countries China
Conditions gastric cancer
Interventions Experiment group:Kangai injection 60ml ivgtt D1-10 Q21d, combined with Chemotherapy OFL: L-OHP 130mg/m2 ivgtt d1, CF 200mg ivgtt d1-5, 5-FU 500 mg/m2 ivgtt d1-5, Q21d;Control group:Chemotherapy OFL: L-OHP 130mg/m2 ivgtt d1, CF 200mg ivgtt…
Registration date Oct 9, 2013
Target size Experiment group:75;Control group:75
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations